Incyte Corp (NASDAQ:INCY)
The Company is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
bclear2
(< 20)
Submitted: 5/8/2013 2:25:20 AM :
Start Price:
$21.71
INCY Score:
+3.34
promising JAK inhibitors with big potential in treating various cancers and inflammatory diseases such as rheumatoid arthritis and psoriasis.
Recs
ayuddha
(< 20)
Submitted: 7/15/2012 5:18:50 PM :
Start Price:
$25.50
INCY Score:
-32.90
It was picked by www.hechtsoft.de Trade Alerts.
Recs
portefeuille
(99.78)
Submitted: 12/15/2011 11:24:11 PM :
Start Price:
$16.09
INCY Score:
+13.28
There are currently 800 INCY shares in my "fund" with break-even of around 2.69 USD. http://caps.fool.com/Blogs/fund-trades/678775.
Recs
p1a5244
(85.31)
Submitted: 9/18/2011 11:15:17 PM :
Start Price:
$14.35
INCY Score:
+20.89
9/18/11 Options Predictor Rank #12. P/C Ratio 0.015 and Call Sizzle 4.756.
Recs
thl101
(< 20)
Submitted: 7/9/2011 10:57:24 AM :
Start Price:
$19.57
INCY Score:
-8.02
Incyte is entering a critical phase of its transition from a biotech into a pharmaceutical. Having made strategic alliances with big pharma, it has reduced its developmental liabilities while maintaining control of its primary drugs in the US market. As the indications its drugs are targeting have few to no current effective therapies, Incyte will be positioned to gain market share rapidly and expand earnings quickly.
Recs
oncqueen
(66.61)
Submitted: 6/6/2011 10:13:02 AM :
Start Price:
$17.09
INCY Score:
+6.00
This is a "first-to-the-table" drug for a class of disorders for which current treament is a hassle (periodic large volume bloodletting) or can cause other significant problems (making other blood counts worse, with a risk of bleeding and infection).
Recs
jmad0
(< 20)
Submitted: 2/4/2011 3:29:47 AM :
Start Price:
$14.86
INCY Score:
+27.45
I have owned and watched INCY since Oct. 2008 and still think it is a nifty little company with plenty of potential to do good. Maybe it's because I have an orphan disease ... hey, "buy what you know."
Recs
5starman
(< 20)
Submitted: 9/15/2010 7:53:46 PM :
Start Price:
$14.20
INCY Score:
+14.17
New drug for rare blood cancer.
Recs
Cosmo21
(< 20)
Submitted: 6/7/2010 5:04:58 PM :
Start Price:
$12.03
INCY Score:
+33.39
If you saw the news out by the fool today on INCY you would realize they really are foolish. What kind of idiot recycles a story from march and trashes a company is doing all the right things, unless they are short! Do your own homework and you find a great pipeline, collaberations with big pharma and a well develpoed r&d.
<br /><br />Don't be fooled, get long!
Recs
markymark69
(< 20)
Submitted: 3/23/2010 3:42:55 PM :
Start Price:
$14.16
INCY Score:
+20.54
I bought into this stock on 03/05/2010 @ $11.53. So far its one my best performing stocks. My wife works for a CRO (not involved with any INCY's studies) and looked at INCY's pipeline. An effective oral arthritis drug in the pipeline will send this stock thru the roof if it makes it thru phase II trials. Its currently about 3 months into the phase II trial.
Recs
WakiDay
(< 20)
Submitted: 1/8/2010 12:27:21 PM :
Start Price:
$10.86
INCY Score:
+65.90
GREAT drug development stock.
Recs
TMFBiologyFool
(99.13)
Submitted: 12/21/2009 4:15:23 PM :
Start Price:
$8.72
INCY Score:
-114.59
$1 billion market cap is too big for the pipeline.
Recs
lonewulf47638
(61.24)
Submitted: 12/18/2009 12:04:14 PM :
Start Price:
$8.44
INCY Score:
+120.58
good news today on new drug. growth will happeen soon.
Recs
MDmomma
(< 20)
Submitted: 12/8/2009 11:38:58 AM :
Start Price:
$8.00
INCY Score:
+136.44
Successful JAK2 inhibition has great potential in both hematologic and rheumatologic disease. Being an oral drug could actually be a drawback, as injectable drugs are usually covered by insurances and oral ones less so.
Recs
bklynmp3j
(98.87)
Submitted: 8/25/2009 12:23:31 AM :
Start Price:
$6.15
INCY Score:
+212.32
insider buying
Recs
slimjim2005007
(< 20)
Submitted: 6/9/2009 11:04:40 PM :
Start Price:
$3.42
INCY Score:
+495.53
INCY DIABETIC DRUG COULD BE WORTH A BILLION DOLLARS
THEY ALSO HAVE A FEW OTHER DRUGS COMING UP WORTH THE SAME AMOUNT, A BILLION DOLLAR COMPANY IN THE WORKS.
Recs
gridster
(27.84)
Submitted: 4/10/2008 1:35:56 PM :
Start Price:
$10.98
INCY Score:
+82.92
Incy is on the threshhold of new and innovative drug therapy for various cancers. Their genetic research is fantastic and will prove to be very rewarding over the next year or two
Recs
ScienceInvestor
(90.13)
Submitted: 3/21/2008 8:59:59 PM :
Start Price:
$9.54
INCY Score:
+111.65
Great product line for the speculative investor. The company carries a lot of debt that will be offset with an approved drug candidate. The growth from the potential product pipeline is the attractive aspect of this security. I don't have a crystal ball, but assuming the big pipeline drugs prove positive this is a high flyer and I'm putting some of my chips on INCY and their product pipeline....
Recs
PPT1
(58.64)
Submitted: 2/13/2008 11:11:11 AM :
Start Price:
$12.05
INCY Score:
+63.05
Innovative drug pipeline for common diseases such as Diabetes
Recs
mroth5745
(< 20)
Submitted: 12/18/2007 2:31:00 PM :
Start Price:
$10.64
INCY Score:
+96.90
In the pipeline with good trials
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 36 : 1 2 Next »